Mounjaro Tirzepatide Injection 15 Mg Box

12,000.00 - 18,000.00 / Box
Business Type Manufacturer, Exporter, Supplier, Retailer, Wholesaler, Trader, Distributor, Importer, Buying House
Type Box
Brand Mounjaro Tirzepatide Injection
Material Injection
Click to view more

Preferred Buyer From

Location Worldwide

Product Details

Product Code
02045000
Payment Terms
L/C, D/A, D/P, T/T, Western Union, Other
Delivery Time
2 - 3 days

Mounjaro Tirzepatide Injection


Mounjaro (Tirzepatide) Injection


Product Description


 


Eli Lilly and Company is proud to announce that the U.S. Food and Drug Administration (FDA) approved Mounjaro™ (tirzepatide) injection for the treatment of adults with type 2 diabetes as an adjunct to diet and exercise. The approval of Mounjaro represents the first new class of diabetes medication introduced in nearly a decade.Mounjaro is the first and only approved once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is a single molecule that targets the body's receptors for GIP and GLP-1, which are natural incretin hormones. Results from the global phase 3 SURPASS program supported this approval.

Yes! I am interested

Looking for "Mounjaro Tirzepatide Injection 15 Mg Box" ?

Box

Explore More Products


Close

Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us